Peptide Therapeutics To Retain Vaccines; Spins Off Small Molecules
Executive Summary
Cambridge, U.K.-based Peptide Therapeutics will retain its travel vaccine focus, following the spin off of its drug discovery activities into a new entity called NewCo.